Former Meta and Time Warner exec Mark D'Arcy is joining Microsoft as a corporate vice president working on the tech ...

D Molecular Therapeutics, Inc.’s FDMT share price has dipped by 5.25%, which has investors questioning if this is right time to buy.

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 4 undervalued stocks in the Pharmaceuticals industry for Friday, May 09, 2025. Let’s take a ...

Showcase your company news with guaranteed exposure both in print and online The Future of Bay Area Biotech: Searching For Answers The Small Business Leaders awards program honors the dedicated ...